InnoMedica Ransomware Attack
Ransomware victimData extortion
About this victim
[AI generated] InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.
Overview
View group profileIndustry
Manufacturing
Country
Switzerland
Discovered
over 1 year ago
Attack date
May 26, 2025
Confidence
85%
Severity
Medium
Status
Claimed
Threat group
worldleaksTotal victims
73
First seen
Nov 2025
Last seen
Jul 2026
Group status
active
Sophistication
0
Impact score
67
Threat level
4.2/10Status breakdown
Victim's position within group
Industry
Manufacturing
Known target sector
Country
Switzerland
Frequently targeted country
Other victims
View all (73)Same group · worldleaks
Group activity
Monthly attacks · worldleaks
73
total · avg 8.1/mo